Does nmn Improve Sleep? What Human Studies Show

Why do people connect NMN and sleep?

NMN, or nicotinamide mononucleotide, is studied as a precursor that can contribute to NAD+ production. NAD+ participates in cellular metabolism and other biological processes. Researchers have explored whether these pathways relate to age-associated changes in sleep, daytime alertness, or fatigue. This is a research question—not evidence that taking NMN will make someone fall asleep faster or sleep more deeply.

A common leap in supplement marketing is to move from “NAD+ biology is connected with circadian processes” to “NMN resets the body clock and fixes sleep.” Those are different statements. A plausible mechanism can justify a clinical study, but a human trial must show that people taking NMN sleep better than comparable people taking a placebo. A change in a blood NAD+ measurement would still be a biomarker result; it would not, by itself, demonstrate a sleep benefit.

The useful question is therefore not whether the pathway sounds relevant, but what the sleep outcomes in controlled human studies show, how they were measured, and whether the results were different from placebo.

What have human NMN sleep studies actually found?

The available trials are small, short, and conducted in selected groups of adults. They do not establish an NMN sleep treatment or show that results apply to younger adults, people with diagnosed insomnia, every product, or long-term use.

A 2026 systematic review and network meta-analysis combined 27 studies of several NAD+ precursors, including NMN, NR, NADH, and nicotinamide. Across this broader evidence set, the authors reported no significant improvement in sleep quality for any precursor.[4] Because it pooled different compounds, populations, and sleep measures, it is not a final NMN-only answer. It does, however, argue against presenting NMN as a clinically established sleep solution.

How should you interpret mixed results and sleep scores?

The 2022 and 2024 trials are not identical experiments. They enrolled different participants and gave sleep outcomes different roles in the study. In the 2022 trial, sleep quality was assessed across morning and evening NMN and placebo groups; the main sleep-score comparison did not show a significant group-by-time interaction. In the 2024 study, sleep was a secondary outcome while the primary focus was physical function. A positive result on a secondary questionnaire measure is worth reporting, but it does not outweigh the need for larger studies designed specifically to test sleep.

It also matters whether a reported change occurred within one group or was significantly greater than the change in the placebo group. People in both groups can report better scores over time because of ordinary variation, expectation, changes in routine, or repeated measurement. A larger-looking effect size inside the NMN group is not automatically proof that NMN caused the difference.

The trials used the PSQI, a questionnaire about a person’s reported sleep over a recent period. A questionnaire can be useful, but it is not the same as a sleep-laboratory measurement of sleep stages. The results do not support precise claims such as “NMN increases deep sleep by a certain percentage,” “restores sleep architecture,” or “makes people fall asleep a stated percentage faster.” Such claims require direct, reliable evidence for those exact outcomes.

The fairest summary is that one small trial reported improvements on selected self-reported sleep measures, another did not find a significant NMN-specific effect on the main sleep analysis, and a recent pooled review did not find a significant sleep-quality benefit across NAD+ precursors. More sleep-focused, independently replicated trials are needed.

What would make the evidence more convincing?

A stronger answer would come from trials planned around sleep as the main research question, with enough participants to detect a meaningful difference and a clearly defined group of people being studied. Researchers would need to set the primary sleep outcome in advance, compare NMN with a matching placebo, report all planned outcomes, and repeat the result independently. If a claim is specifically about deep sleep or sleep stages, a questionnaire alone is not enough; objective sleep measurement would be needed alongside how participants feel.

Timing questions also need a direct design: morning and evening groups, comparable routines, a prespecified analysis, and enough participants to tell whether one schedule performs differently. A trial that simply notices a larger change in one small subgroup after the fact cannot establish the best time to take NMN. Until that kind of evidence is available, timing and dose claims should remain limited to what was tested.

Does NMN work better for sleep at night or at a certain dose?

No best time of day has been established for improving sleep. The 2022 trial included morning and evening dosing, but it did not demonstrate a statistically significant sleep-score advantage that would justify recommending one time over the other. The within-group pattern that looked largest in the evening NMN group should not be turned into “take NMN at night for better sleep.” It was not proof of a reliable timing effect.

Likewise, there is no validated NMN dose for sleep. The 250 mg amount in these trials describes what researchers tested for a limited period in specific participants; it is not a personal recommendation, a proven minimum, or a proven sleep dose. Do not use an online age-and-weight calculator or increase a serving to chase a sleep effect that has not been established. For a broader explanation of how to read NMN study amounts, see AIDEVI’s NMN dosage-by-age evidence guide.

When you see a product page claim that NMN improves sleep, check whether its cited study tested the same ingredient, amount, and population—and whether sleep was a primary outcome or one of several secondary measures. A rise in blood NAD+, a result in cells or animals, or a customer story does not demonstrate that a finished product improves human sleep. Be cautious with exact percentages unless the source reports a direct comparison with placebo and measures that same outcome.

If you already take NMN and are unsure about timing, follow the exact product label and any advice from your healthcare professional. The sleep studies do not provide enough evidence to prescribe a bedtime schedule. Do not replace or change prescribed treatment based on a supplement article.

What should you do if sleep is still a problem?

Recurring sleep difficulty deserves attention to the cause, not just another supplement. A brief sleep diary can help you record bedtime, wake time, awakenings, daytime sleepiness, caffeine or alcohol, new medicines, and when a supplement was started. This record may help you and a clinician look for a pattern; it cannot diagnose a sleep disorder or prove that NMN caused a change.

When reviewing the diary, look for changes that happened around the same time: later caffeine, evening alcohol, a shift in work hours, travel, pain, stress, or a new medicine. These are prompts for a clinical conversation, not a checklist for diagnosing yourself. Loud snoring, gasping or pauses in breathing during sleep, severe daytime sleepiness, or a sudden major change in sleep are also reasons to ask about evaluation rather than trying to correct the problem by changing NMN timing.

If sleep problems persist, affect daytime functioning, or come with concerning symptoms, discuss them with a healthcare professional. Chronic insomnia can have several contributors, including schedule, stress, medication effects, pain, mood, or another sleep or health condition. The American Academy of Sleep Medicine recommends multicomponent cognitive behavioral therapy for insomnia (CBT-I) for adults with chronic insomnia; it does not recommend sleep hygiene as the only treatment.[5] This is a more evidence-based direction to discuss than relying on NMN to treat insomnia.

If you suspect a supplement is affecting your sleep, note the exact product, serving, and timing and discuss whether to pause or change it with a qualified professional, especially if you take medication or manage a medical condition. Do not add multiple sleep supplements at once; doing so makes it harder to identify what is helping or causing an unwanted effect.

Frequently asked questions

Can NMN improve sleep quality?

It has not been established. A small 2024 trial reported better scores on selected self-reported measures, but a 2022 trial did not show a significant NMN-specific sleep-score effect, and broader pooled evidence remains uncertain.

Does NMN increase deep sleep?

The cited human trials used questionnaires such as the PSQI. They do not substantiate a specific increase in deep sleep or prove that NMN restores sleep architecture.

Should I take NMN before bed?

There is no evidence-based bedtime recommendation. One study compared morning and evening schedules but did not establish that evening dosing improves sleep more than placebo.

Can NMN replace melatonin or insomnia treatment?

No. NMN has not been established as an insomnia treatment or as a substitute for a prescribed medicine or a clinician-recommended plan. Talk with your healthcare professional before changing treatment.

Does NMN reset your circadian rhythm?

Human research has not established that an NMN supplement resets the body clock or treats circadian rhythm disorders. Biological links are a reason to study NMN, not proof of that outcome.

What if I feel my sleep got worse after starting NMN?

Record when the change started, the exact product and serving, and other routine changes. Do not raise the amount to counter a sleep problem. Ask a healthcare professional whether to pause or change the supplement, especially if you take medication or have a health condition.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.